Description:
This session will explore diagnosis, management and treatment of liver disease in the patient with obesity and how obesity treatments affect progression or regression of NASH/NAFLD.
Learning Objectives:
- Understand pathophysiology of NASH/NAFLD.
- Learn how to evaluate liver disease severity.
- Compare medical and surgical treatment options.
- Consider procedure choices in a pre or post liver transplant patient.
- Evaluate MBS influence on primary liver cancer.
| 1:15pm |
Introduction Rachel L Moore, MD FACS Dipl.ABOM |
| 1:20pm |
Pathophysiology, Incidence and Staging of NAFLD Catherine Hudson, MD |
| 1:35pm |
Invasive and Noninvasive Ways to Assess Liver Disease Severity Helmuth T Billy, MD |
| 1:50pm |
Medical Management of NAFLD Options and Outcomes Holly F. Lofton, MD |
| 2:05pm |
Impact of MBS and Endoscopic Procedures on NAFLD Progression Shauna Levy, MD MS FACS FASMBS DABOM |
| 2:20pm |
Prevalence of Liver Transplant for NAFLD and Anatomic Considerations for Bariatric Surgeons Rana Pullatt, MD |
| 2:35pm |
Metabolic and Bariatric Surgery Affect on Primary Liver Cancer Scott Shikora, MD FACS |
| 2:50pm |
Discussion |
| 3:10pm |
Conclusion Rachel L Moore, MD FACS Dipl.ABOM |
| 3:15pm | Adjourn |